Background: The knowledge about chronic spontaneous urticaria (CSU) phenotypes
minimum period of 6 weeks. 2, 3 An episode of CSU can last longer, even more than 5 years and more than one CSU episode can be suffered. CSU negatively affects the patient's quality of life and has a considerable impact on direct and indirect health-related costs. 4 The current knowledge about CSU phenotypes is based on its clinical characteristics, associated comorbidities, activity, course, and response to the available effective drugs. The CSU phenotype showing the most active disease (highest urticaria activity score [UAS])
with the worse prognosis commonly is refractory to high doses of antihistamines and associates angioedema, concomitant chronic inducible urticaria (CIndU), and/or serum autoreactivity (functional histamine-release autoantibodies). 4 Mast cell activation and wheal kinetics are partially understood and explain the evanescent nature of hives. However, our knowledge about the biological characteristics of the apparently healthy skin during urticaria outbreak is unknown.
The genotype expression and its further correlation with CSU phenotypes are unknown. 5 Functional analysis of gene expression from lesional and nonlesional CSU (LS-CSU and NLS-CSU, respectively) skin may provide new insights into the pathogenesis of hive.
We describe the genetic signature of patients suffering severely active CSU refractory to antihistamine treatment. [6] [7] [8] Our hypothesis
is that the entire cutaneous integument provides a peculiar gene expression in severely active CSU.
2 | ME TH ODS
| Studied population: CSU patients and HCs
Twenty patients suffering from severely active CSU and 10 HCs were prospectively included in the study. Only patients showing severely active CSU (urticaria activity score [UAS] 7≥16) for at least 3 months were included. 9 All patients remained symptomatic despite 
| Clinical assessment and interventions
CSU patients were evaluated through a complete clinical history.
Complementary tests were performed according to an extended diagnostic program 2 (Table S1 ).
Three cutaneous biopsies (punch of 4 mm) were obtained from the skin: two biopsy specimens from an active wheal or LS-CSU and one from NLS-CSU. Samples were taken from LS-CSU (located on the trunk) with a minimum-maximum evolution time of 1-2 hours.
The NLS-CSU skin biopsy was obtained from an area where neither a wheal nor other skin alterations (eg, desquamation or pigmentation) were presented within the previous 72 hours. Biopsies were prepared for routine pathology (hematoxylin-eosin and Giemsa stains), mast cell and basophil-specific immunohistochemistry (c-Kit and BB1 expression), and transcriptome analysis (quick-freezing and cryopreserved tissue stored at -80°C. Briefly, 600 ng Cy3-labeled fragmented cRNA in hybridization buffer was hybridized overnight (17 hours, 65°C) to Agilent whole human genome oligo microarrays 8x60K v2 using Agilent's recommended hybridization chamber and oven. Finally, the microarrays were washed once with the Agilent gene expression wash buffer 1 for 1 minute at room temperature followed by a second wash with preheated Agilent gene expression wash buffer 2 (37°C) for 1 minute.
| Bioinformatic analysis of the gene array
Blood data and tissue data were analyzed separately. Raw data were extracted file by file using R (v 2.15) and package Biobase. After GIM ENEZ-ARNAU ET AL.
| 1779 quality control assessment, gene transcripts obtained were background corrected and normalized between arrays with quantile normalization available in Limma package. The noise caused by nonexpressed transcripts was avoided doing a selection of those having a standard deviation (SD) above the 20% of SD distribution.
A total of 46 973 gene identifiers were selected for both data sets.
Linear models for microarrays (Limma package), 10, 11 with a false discovery rate (FDR) 12 multiple comparison correction, were used to detect differentially expressed transcripts between the conditions specified in Figure S1 . Linear models were controlled by age. Variable sex was studied, but no differences between groups were presented, so it was not included in the model. An adjusted P value of <.05 and an absolute logarithmic fold change (logFC) from 1 (ie, logFC>1 or <À1) were considered the significant thresholds to select final significant transcripts.
Functional analysis was performed as a first step with the Ingenuity Pathway Analysis (IPA) (http://www.ingenuity.com). All lists were loaded and a core analysis performed.
In order to study of tendencies among conditions (LS-CSU, NLS-CSU, and HCs skin), a regression approach to find clusters of genes with similar expression profiles was performed (maSigPro package).
13
In addition to our data, public data under accession number [16] [17] [18] [19] [20] qPCR data analysis was performed using the geNorm method for the selection of the best housekeeping genes, 21 and the 2 ÀDDCt method 22 was applied. Student's t tests (paired and unpaired) were applied, and genes were considered to be differentially expressed when P value was <.05. The confirmed genes by qPCR of the tissue and the blood were studied according to the comparisons included in Figure S1 .
3 | RESULTS
| Characteristics of the studied population
The clinical features for each patient are included in Table S2 . associated. 4 The autoimmune thyroid diseases were the most frequent concomitant conditions, affecting 25% (5/20) of the CSU patients. 4 Other autoimmune diseases reported included vitiligo, Sj€ ogren syndrome, and systemic lupus erythematosus. D-dimer serum level was high in 54% (7/13). The mean value of the total serum IgE was 277.5AE SD357.8 UI/mL (range 22-1470 UI/mL), slightly higher compared to the normal values detected in HCs (60.7AESD 54.4 UI/mL).
Histopathological findings were compatible with a well-developed wheal. The epidermis always showed a normal appearance.
Edema was present in upper and mid-dermis. A characteristic of both superficial and deep perivascular/interstitial inflammatory infiltrate with lymphocytes, eosinophils, and neutrophils without vascular damage, was observed in all cases ( Figure S2 ). A mild to moderate increase of mast cell numbers was also observed. No morphological differences were found between the wheal samples studied in terms of edema intensity, location of the inflammatory infiltrate, and predominant type of cells involved.
| NLS-CSU transcriptome in CSU shows an abnormal mRNA expression of genes involved epidermal homeostasis
Based on the statistical criteria defined previously, 376 identifiers corresponding to 299 unique genes were differentially expressed ( Figure 1A ). Thirty-nine genes were selected for validation using qPCR; from those, 31 were confirmed (79.48%) ( Figure 1B ). Table 1 includes the genes confirmed by qPCR resulting from the compar- (Table S4 ).
The functional networks relating differentially expressed genes are built around IL-1a, IL-6, CCL2, and FOSB. IL-1a and IL-6 are related with genes responsible for proteins involved in the cellular movement, inflammatory response, or hematological system. CCL2
and FOSB gene is being related with other genes involved in connective tissue disorders, inflammatory disease, and skeletal and muscular disorder (Figure 3 ).
T A B L E 1 Genes confirmed by qPCR resulting from the comparison between the NLS-CSU with the skin from the HCs and its main biological function (ordered by logFC) HCs, healthy controls; logFC, logarithmic fold change; NLS-CSU, nonlesional skin-chronic spontaneous urticaria; qPCR, quantitative real-time polymerase chain reaction. *logFC from 1 (that is, >1 or <À1). **adj P value: adjusted P value.
| Time course analysis of differentially expressed genes from HCs to NLS-CSU and LS-CSU
A total of 3,039 genes were differentially expressed between the skin of HCs and LS-CSU. This list included genes that were confirmed as differentially expressed in previous comparisons. To investigate the behavior of these genes, a time course analysis was conducted using the MaSigPro methodology. 13 From the 204 Agilent probes collected at the three conditions (healthy skin from HCs, NLS-CSU and LS-CSU), four different clusters were considered: two with a clear increasing pattern and two with a decreasing pattern (Figure 4) . These results show that progression of differentially expressed genes is uniformly increased or decreased along the skin worsening until the wheal appearance.
| CSU patients' blood gene expression compared with HCs
There were no differences in blood gene expression between groups, according to the established statistical criteria.
| DISCUSSION
Our study was focused in the genetic signature of a particular subset of patients suffering from severely active CSU. In our series, the mean UAS7 was 33.6 (range 16-42).
25-28
Patients suffering from CSU continuously generate edematous and evanescent lesions developing all over the skin of the entire body secondary to different triggers systemically driven. Apparently normal or healthy skin in severe CSU patients is genetically different from normal skin in HCs; according with our results, an overexpression of genes mainly involved in epidermal terminal differentiation, barrier function, inflammation, and dermal repair is shown.
Despite CSU is not an a priori epidermal disorder, we observed an overexpression of genes involved in terminal epidermal differentiation and barrier function both in LS-CSU vs NL-CSU (21 genes) and NLS-CSU vs skin from HCs (19 genes) comparisons. A differentially profile of genes involved in epidermal homeostasis was observed between both comparisons. For example, LS-CSU vs NLS-CSU showed involucrin and aquaporin-3 overexpression, whereas NLS-CSU vs skin from HCs disclosed filaggrin overexpression (Table S5 ). The influence of dermal inflammation in epidermal homeostasis has been demonstrated in several cutaneous inflammatory disorders, such as atopic dermatitis or psoriasis, but the relevance of this phenomenon in CSU has not been defined. In a recent study conducted in 16 Korean patients with CSU/CIU, an increased expression of the gene that codifies the filaggrin was observed (by qPCR and immunohistochemistry). Additionally, a potential relationship between filaggrin gene expression and urticaria activity was detected. 29 The authors found an increased amount of cis-urocanic acid (filaggrin metabolite) in the CSU epidermis and speculate about its pathogenic potential role. Although this study cannot be methodologically compared with our study (eg, the urticaria activity was based in a different score), LMOD1  LDLR  CH25H  NR4A3  NR4A2  MYC  IRF1  FPR1  FOSL1  EGR1  CSRNP1  ATF3  ZFP36  TUBB2A  STEAP4  SRGN  SLC25A25  RGS5  RGS16  RGS1  PDE5A  NAMPT  MT2A  DDX21  AKR1B10  TLR2  LILRB4  LILRB3  IL4R  FCGR3A  PNP  CD69  TIMP3  DUSP1  ADAMTS8  ADAMTS4  ADAMTS1  PTGS2  PLA2G3  FFAR2  FCGR1B  SERPINA3  CSF3R  AREG  FOSB  SPRR2G  SPRR2F  SPRR2D  SPRR2C  SPRR2B  SPRR2A  SPRR1B  SPRR1A  KRTAP9− KRT6C  KRT16  IVL  AQP3  HAS3  FGFBP1  TNFRSF12A  TNFRSF10C  TNFAIP6  SOCS3  IL6  IL1B  C10orf99  C5AR1  VWF  THBS1  SOD2  SERPINE1  SERPINB3  SERPINA1  PTAFR  PLAUR  LILRB2  CXCR2  CXCL2  CXCL12  CXCL1  CCL8  CCL4  CCL2  CCL18  CCL14  S100A9  S100A8  S100A7  S100A2  VNN2  SELE  ICAM1  CYR61  PI3   −3 The wheal defines urticaria as the consequence of the activation of the skin mast cells, the activity of the released mediators, and the recruited cells. LS-CSU group showed a plethora of genetic information resulting in a very active inflammatory process. The role of some of the proteins codified by these genes is well known. This is 42 or intracellular transcriptional factors (FOSB) 43 . Some of them are a therapeutic target for CSU (eg, as IL-1B, with relevance in auto-inflammatory syndromes).
Genes regulating intracellular signals as the regulators of G-protein signaling (RGS) appear interesting. RGS 16 and 1 were overexpressed, whereas RGS5 (expressed by neutrophils) was under expressed. It has been described the regulation of FceRI in mast cells through agonist-induced phosphorylation of G-protein-coupled receptors by GPCR kinases promoting their desensitization and internalization. 44 The overexpression of the genes codifying FceRI in LS-CSU and NLS-CSU and its further down regulation using omalizumab has been described by expression microarrays considering just the P value without qPCR confirmation. 45 We have also detected an overexpression of genes that codify the FceRI (FCER1A and FCER1G) in both LS-CSU and NLS-CSU compared to HCs considering the P value (not the adjusted P value), being the log FC good, over 1,2. As it was expected for methodological reasons, the confirmation of FCER1A and FCER1G overexpression by qPCR was not achieved (Table S3) .
Other differentially expressed genes in the LS-CSU with a patho- Methodological differences aside, the current results go in agreement with the study of Patel et al. 46 Some common genes were found in their and our study including SELE, CH25H, CCL2, MT2A, CD69, SRGN, ADAMTS, STEAP4, S100A8, THBS1, and TNFAIP6.
Also, some common functional pathways involved in the disease, such as cellular movement, inflammatory response, cell-to-cell signaling, tissue development, or the hematological systems are described.
The study of tendencies among conditions (LS-CSU, NLS-CSU, and HCs skin) showed a uniform increased or decreased gene progression along the skin worsening from the HCs to the LS-CSU.
Conversely, from the genetic point of view, no significant differences in gene expression were observed between the blood of the CSU patients and that of HCs.
The genes studied accomplished both the experimental defined 
F I G U R E 4
Behavior of the genes differentially expressed from the skin of the HCs to the LS-CSU. From the 204 Agilent probes collected at the three conditions (healthy skin from HCs, NLS-CSU, and LS-CSU), four different clusters were considered: two with a clear increasing pattern and two with a decreasing pattern. The progression of differentially expressed genes is uniformly increased or decreased along the skin worsening until the wheal appearance
